Abstract:We used a novel mouse model combined with transcriptomic profiling as well as morphological and functional assessments to investigate the pathophysiology of hidden hearing loss. We found that hidden hearing loss is linked to transcriptomic alterations indicating disruption in various molecular and cellular pathways in the cochlear sensorineural structures. Additionally, hidden hearing loss is associated with increased susceptibility to overt hearing loss in response to noise exposure and aging. Presbycusis is a prevalent condition in older adults characterized by the progressive loss of hearing due to age‐related changes in the cochlea, the auditory portion of the inner ear. Many adults also struggle with understanding speech in noise despite having normal auditory thresholds, a condition termed "hidden" hearing loss because it evades standard audiological assessments. Examination of animal models and postmortem human tissue suggests that hidden hearing loss is also associated with age‐related changes in the cochlea and may, therefore, precede overt age‐related hearing loss. Nevertheless, the pathological mechanisms underlying hidden hearing loss are not understood, which hinders the development of diagnostic biomarkers and effective treatments for age‐related hearing loss. To fill these gaps in knowledge, we leveraged a combination of tools, including transcriptomic profiling and morphological and functional assessments, to identify these processes and examine the transition from hidden to overt hearing loss. As a novel approach, we took advantage of a recently characterized model of hidden hearing loss: Kcnt1/2 double knockout mice. Using this model, we find that even before observable morphological pathology, hidden hearing loss is associated with significant alteration in several processes, notably proteostasis, in the cochlear sensorineural structures, and increased susceptibility to overt hearing loss in response to noise exposure and aging. Our findings provide the first insight into the pathophysiology associated with the earliest and, therefore, most treatable stages of hearing loss and provide critical insight directing future investigation of pharmaceutical strategies to slow and possibly prevent overt age‐related hearing loss.

Pathophysiological processes underlying hidden hearing loss revealed in Kcnt1/2 double knockout mice